Skip to content
value.today

BeneMedical, LLC

Total raised
$4 M
2 rounds on record
Latest round
$2 M
Apr 2019
First round on record
Aug 2018
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BeneMedical, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2019$2 MNo. 2Under $2 million

BeneMedical, LLC: Raise no. 2, Apr 2019

Investors in this round

9 investors had bought by the notice of May 6, 2019: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$250,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Mississippi

People named in the notice

  • Chris V. Posey · Executive Officer
  • Debbie Landers · Executive Officer
  • Dr. Rambod V. Rouhbakhsh · Executive Officer
  • Kirk V. Scott · Executive Officer
  • Linda Rebrovick · Executive Officer
  • Michael V. Forster · Executive Officer, Director
  • Christopher H. Hughes · Director
  • David V. Forster · Director
  • E.L. V. V · Director
  • Garry V. Hughes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Forster, Chief Executive Officers. Source: SEC Form D, newest notice filed May 6, 2019. Read the notice at the SEC.

debt, optionsSEC
Aug 2018$2 MNo. 1$2 to $10 million

BeneMedical, LLC: Raise no. 1, Aug 2018

Investors in this round

6 investors had bought by the notice of Sep 11, 2018: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
$250,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$280,000 (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Mississippi

People named in the notice

  • Buster Brown · Executive Officer
  • Dr. Rambod V. Rouhbakhs · Executive Officer
  • Kirk V. Scott · Executive Officer
  • William T. Lee, Jr. · Executive Officer
  • Christopher H. Hughes · Director
  • David V. Forster · Director
  • E.L. V. Vowell · Director
  • Garry V. Hughes · Director
  • Mike V. Forster · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William T. Lee, Jr., Chief Operating Officer/Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 11, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BeneMedical, LLC had revenue of up to $1 million when it filed its newest notice of a funding round (May 2019).

    SEC Form D (revenue range) · May 2019

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2019

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BeneMedical, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BeneMedical, LLC
NameRoleNamed in
Chris V. PoseyExecutive officerMay 2019
Debbie LandersExecutive officerMay 2019
Dr. Rambod V. RouhbakhshExecutive officerMay 2019
Kirk V. ScottExecutive officerMay 2019
Linda RebrovickExecutive officerMay 2019
Michael V. ForsterExecutive officerMay 2019
Buster BrownExecutive officerSep 2018
Dr. Rambod V. RouhbakhsExecutive officerSep 2018
William T. Lee, Jr.Executive officerSep 2018
Christopher H. HughesDirectorMay 2019
David V. ForsterDirectorMay 2019
E.L. V. VDirectorMay 2019
Garry V. HughesDirectorMay 2019
Michael V. ForsterDirectorMay 2019
E.L. V. VowellDirectorSep 2018
Mike V. ForsterDirectorSep 2018